If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImperial Innovations Group Regulatory News (IVO)

  • There is currently no data for IVO

Update on possible offer

23 May 2017 12:05

RNS Number : 9809F
IP Group PLC
23 May 2017
 

THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES OR IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

 

THIS ANNOUNCEMENT CONSTITUTES INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO.596/2014

 

IP Group plc ("IP Group" or the "Company") - update on possible offer for Touchstone Innovations plc ("Touchstone") and Rule 2.9 information

 

Further to the announcement made by IP Group earlier today regarding a possible offer for Touchstone (the "Possible Offer") and in accordance with Rule 2.10 of the City Code on Takeovers and Mergers (the "Code"), IP Group announces that it has now received irrevocable undertakings from Invesco Asset Management Ltd ("Invesco") and Lansdowne Developed Markets Master Fund Limited ("Lansdowne") in connection with the Possible Offer and a letter of intent from Lansdowne in connection with the Possible Offer.

 

Following this, IP Group has received irrevocable undertakings or letters of intent in support of the Possible Offer from Touchstone shareholders representing, in aggregate, 74.3 per cent of Touchstone's issued share capital. Updated and cumulative tables of all irrevocable commitments and of all letters of intent received in favour of the Company in connection with the Possible Offer are set out below.

 

1. Irrevocable undertakings

 

Name of Touchstone shareholder

Number of Touchstone shares over which undertaking is given

Percentage of Touchstone issued share capital as at 31 January 2017

Woodford Investment Management Ltd

16,120,413

10.0000

Invesco Asset Management Ltd

16,120,000

9.9997

Lansdowne Developed Markets Master Fund Limited

16,120,000

9.9997

Total

48,360,413

29.9995

 

The irrevocable undertakings from Lansdowne and Invesco respectively remain binding in the event of a higher, or any other, bid or offer for Touchstone.

The Lansdowne irrevocable undertaking will cease to be binding if, among other things:

i. the Company announces, with the consent of the Takeover Panel, and before the publication of any document containing details of any takeover offer within the meaning of section 974 of the Companies Act 2006 or the publication of any document to be sent to Touchstone shareholders containing amongst other things, details of any proposed scheme of arrangement under Part 26 of the Companies Act 2006 between Touchstone and Touchstone's shareholders in connection with any offer by the Company, that it does not intend to proceed with the Possible Offer and no new, revised or replacement scheme of arrangement or takeover offer is announced by the Company in accordance with Rule 2.7 of the Code;

ii. the takeover offer (or scheme of arrangement as applicable) does not become effective, is withdrawn or lapses in accordance with its terms, save for where the Possible Offer is withdrawn or lapses solely as a result of the Company exercising its right to implement the Possible Offer by way of takeover offer rather than a scheme of arrangement or vice versa or any competing offer is made which is declared wholly unconditional or otherwise becomes effective.

The Invesco irrevocable undertaking will cease to be binding, if among other things:

 

i. any takeover offer (or scheme or arrangement as applicable) does not become effective, is withdrawn or lapses in accordance with its terms by 30 November 2017 or such later date as the Company and Touchstone may agree in writing, save for where the Possible Offer is withdrawn or lapses solely as a result of the Company exercising its right to implement the Possible Offer by way of takeover offer rather than a scheme of arrangement or vice versa or any competing offer is made which is declared wholly unconditional or otherwise becomes effective.

 

The irrevocable undertakings referred to in the table above have been obtained on the basis of a possible offer of 2.1490 IP Group shares for each Touchstone share, subject to adjustments and reservations as set out in the possible offer announcement released by the Company earlier today and available at the Company's website www.ipgroupplc.com/investor-relations/ 

 

2. Letters of intent

The Company has also received a non-binding letter of intent from Lansdowne in favour of the Company representing approximately 12.8 per cent of the share capital of Touchstone in issue on 31 January 2017. The table below summarises the current position as regards the respective letters of intent.

 

Name of Touchstone shareholder

Number of Touchstone shares over which letter of intent is given

Percentage of Touchstone issued share capital as at 31 January 2017

Woodford Investment Management Ltd

20,636,738

12.8016

Invesco Asset Management Ltd

46,750,000

29.0005

Lansdowne Developed Markets Master Fund Limited

4,082,542

2.5325

Total

71,469,280

44.3346

 

 

Rule 2.9 announcement

 

In accordance with Rule 2.9 of the Code, the Company confirms that as at the date of this announcement, it has in issue and admitted to trading on the premium listing segment of the London Stock Exchange 565,221,967 ordinary shares of 2 pence each.

 

The Company holds no shares in treasury.

 

The International Securities Identification Number (ISIN) of the ordinary shares is GB00B128J450.

 

For further information contact:

IP Group plc

 

Alan Aubrey, Chief Executive Officer

+44 (0) 20 7444 0050

Greg Smith, Chief Financial Officer

+44 (0) 20 7444 0070

Liz Vaughan-Adams, Communications

+44 (0) 20 7444 0062/+44 (0) 7979 853802

 

 

Numis Securities Limited (Joint Financial Adviser and Broker)

+44(0) 20 7260 1000

 

Michael Meade

 

James Black

 

Freddie Barnfield

 

 

 

 

Rothschild (Joint Financial Adviser)

+44 (0) 20 7280 5000

 

Warner Mandel

 

 

Anton Black

 

 

 

 

 

Charlotte Street Partners

 

 

Andrew Wilson

+44 (0) 7810 636995

 

Martha Walsh

+44 (0) 7876 245962

 

Important notices

This announcement is not intended to, and does not, constitute or form part of any offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities whether pursuant to this announcement or otherwise. This announcement does not constitute a prospectus or a prospectus equivalent document. The shareholders of IP Group and Touchstone are advised to read carefully the formal documentation in relation to the Possible Offer once it has been despatched.

Overseas jurisdictions

The release, publication or distribution of this announcement in jurisdictions other than the United Kingdom may be restricted by law and therefore any persons who are subject to the laws of any jurisdiction other than the United Kingdom should inform themselves about, and observe any applicable requirements. This announcement has been prepared for the purposes of complying with English law and the Code and the information disclosed in this announcement may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws of jurisdictions outside the United Kingdom.

This announcement is not for publication or distribution, directly or indirectly, in or into the United States of America. This announcement is not an offer of securities for sale into the United States. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1993, as amended, and may not be offered or sold in the United States, except pursuant to an applicable exemption from registration. No public offering of securities is being made in the United States.

Publication of this announcement

In accordance with Rule 26.1 of the Code, a copy of this announcement will be available on the website of IP Group at www.ipgroupplc.com/investor-relations/ by no later than 12 noon (London time) on the business day following this announcement. The content of the website referred to in this announcement is not incorporated into and does not form part of this announcement. A further announcement will be made by IP Group as and when appropriate.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OUPBBGDUDGDBGRX
Date   Source Headline
5th Sep 20162:40 pmRNSHolding(s) in Company
24th Aug 20167:01 amRNSCell Medica and UCL collaboration
12th Jul 20167:02 amRNSCell Medica acquires Delenex Therapeutics
6th Jul 20167:00 amRNSEconic raises £5m to develop novel catalyst tech
30th Jun 201612:11 pmRNSPsiOxus and Bristol-Myers Squibb collaboration
28th Jun 20167:00 amRNSStorm Therapeutics raises £12m
21st Jun 20164:35 pmRNSPrice Monitoring Extension
21st Jun 20167:00 amRNSDirector's share purchase
20th Jun 20167:03 amRNSCircassia cat allergy Phase III study
17th Jun 20167:00 amRNSCell Medica and Baylor College of Medicine partner
16th Jun 201610:44 amRNSReplacement Holding(s) in Company
14th Jun 20163:20 pmRNSEdison issues outlook on Imperial Innovations)
14th Jun 20169:00 amRNSHolding(s) in Company
13th Jun 20167:00 amRNSAllotment of Deferred Placing Shares
31st May 20167:00 amRNSFeaturespace closes £6.2 million funding round
26th May 20167:00 amRNS£3 million funding round for Inflowmatix
11th May 201612:32 pmRNSDavid Newlands appointed Chairman
4th May 20164:35 pmRNSPrice Monitoring Extension
4th May 201611:08 amRNSNexeon raises £30m, plans development lab in Asia
4th May 20167:00 amRNSAnalyst and Investor day
29th Apr 20164:35 pmRNSPrice Monitoring Extension
29th Apr 201612:42 pmRNSSale of Innovations portfolio Stanmore Implants
7th Apr 20167:00 amRNSHalf Yearly Report
21st Mar 20167:00 amRNSDr Martin Knight to step down from the board
18th Mar 201612:40 pmRNSNotice of Results
17th Mar 20167:00 amRNSTopiVert reports successful Phase I clinical study
26th Feb 20168:39 amRNSHolding(s) in Company
25th Feb 20163:59 pmRNSHolding(s) in Company
25th Feb 20163:50 pmRNSHolding(s) in Company
25th Feb 20168:53 amRNSHolding(s) in Company
22nd Feb 20165:01 pmRNSAdmission of shares to trading on AIM
22nd Feb 201612:29 pmRNSResult of General Meeting
22nd Feb 20167:00 amRNS£13.5m funding round in Precision Ocular
11th Feb 20162:51 pmRNSHolding(s) in Company
8th Feb 20167:00 amRNSInnovations leads £5m Series A round in Aqdot
4th Feb 20166:08 pmRNSResult of Placing
4th Feb 20167:00 amRNSPlacing to raise £100 million
2nd Feb 20167:00 amRNSMISSION Therapeutics raises £60 million
26th Jan 20167:00 amRNSInivata completes £31.5m Series A funding round
25th Jan 20167:00 amRNSInnovations joins Apollo consortium
18th Jan 20167:00 amRNSInnovations invests £25m in new £50m UCL Tech Fund
2nd Dec 20157:00 amRNSKesios Therapeutics raises £19 million
19th Nov 20151:51 pmRNSResult of AGM
4th Nov 20151:40 pmRNSGrant of share options
28th Oct 20157:00 amRNSPosting of Annual Report and Notice of AGM
22nd Oct 20157:00 amRNSLeads £1.5m seed funding into AI pioneer, Telectic
14th Oct 20157:00 amRNSFinal Results
22nd Sep 20154:10 pmRNSNotice of Results
12th Aug 20157:00 amRNSIssue of Equity
4th Aug 20157:01 amRNS£2.5m funding round in Oxford Biotrans

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.